168 related articles for article (PubMed ID: 36180132)
1. Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men.
McGrowder D; Tulloch-Reid MK; Coard KCM; McCaw-Binns AM; Ferguson TS; Aiken W; Harrison L; Anderson SG; Jackson MD
Cancer Control; 2022; 29():10732748221131225. PubMed ID: 36180132
[TBL] [Abstract][Full Text] [Related]
2. Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.
Jackson MD; Tulloch-Reid MK; Lindsay CM; Smith G; Bennett FI; McFarlane-Anderson N; Aiken W; Coard KC
Cancer Med; 2015 Jun; 4(6):925-35. PubMed ID: 25858172
[TBL] [Abstract][Full Text] [Related]
3. Prostatic compensation of the vitamin D axis in African American men.
Richards Z; Batai K; Farhat R; Shah E; Makowski A; Gann PH; Kittles R; Nonn L
JCI Insight; 2017 Jan; 2(2):e91054. PubMed ID: 28138564
[No Abstract] [Full Text] [Related]
4. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D levels and the risk of prostate cancer and prostate cancer mortality.
Stroomberg HV; Vojdeman FJ; Madsen CM; Helgstrand JT; Schwarz P; Heegaard AM; Olsen A; Tjønneland A; Struer Lind B; Brasso K; Jørgensen HL; Røder MA
Acta Oncol; 2021 Mar; 60(3):316-322. PubMed ID: 33103532
[TBL] [Abstract][Full Text] [Related]
6. Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study.
Jackson MD; Tulloch-Reid MK; McCaw-Binns AM; Aiken W; Ferguson TS; Bennett NR; Harrison L; Badaloo A; McGrowder D; Grindley A; Walker E; Anderson SG
Cancer Causes Control; 2020 Jul; 31(7):651-662. PubMed ID: 32358695
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency predicts prostate biopsy outcomes.
Murphy AB; Nyame Y; Martin IK; Catalona WJ; Hollowell CM; Nadler RB; Kozlowski JM; Perry KT; Kajdacsy-Balla A; Kittles R
Clin Cancer Res; 2014 May; 20(9):2289-99. PubMed ID: 24789033
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
9. Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.
Nelson SM; Batai K; Ahaghotu C; Agurs-Collins T; Kittles RA
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28036013
[TBL] [Abstract][Full Text] [Related]
10. Association among plasma 1,25(OH)
Ramakrishnan S; Steck SE; Arab L; Zhang H; Bensen JT; Fontham ETH; Johnson CS; Mohler JL; Smith GJ; Su LJ; Woloszynska A
Prostate; 2019 Jul; 79(10):1117-1124. PubMed ID: 31077420
[TBL] [Abstract][Full Text] [Related]
11. Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status.
Paller CJ; Kanaan YM; Beyene DA; Naab TJ; Copeland RL; Tsai HL; Kanarek NF; Hudson TS
Prostate; 2015 Sep; 75(13):1376-83. PubMed ID: 26047130
[TBL] [Abstract][Full Text] [Related]
12. Multiplicative, additive, and interactive associations of 25-hydroxyvitamin D with lung and prostate cancer.
Voutilainen A; Virtanen JK; Hantunen S; Nurmi T; Kokko P; Tuomainen TP
Int J Vitam Nutr Res; 2024 Apr; 94(2):133-142. PubMed ID: 36755523
[No Abstract] [Full Text] [Related]
13. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.
Holt SK; Kolb S; Fu R; Horst R; Feng Z; Stanford JL
Cancer Epidemiol; 2013 Oct; 37(5):666-70. PubMed ID: 23972671
[TBL] [Abstract][Full Text] [Related]
14. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.
Nair-Shalliker V; Bang A; Egger S; Clements M; Gardiner RA; Kricker A; Seibel MJ; Chambers SK; Kimlin MG; Armstrong BK; Smith DP
Sci Rep; 2020 May; 10(1):7736. PubMed ID: 32385370
[TBL] [Abstract][Full Text] [Related]
15. How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study.
Voutilainen A; Virtanen JK; Hantunen S; Nurmi T; Kokko P; Tuomainen TP
Andrologia; 2022 Jul; 54(6):e14410. PubMed ID: 35229338
[TBL] [Abstract][Full Text] [Related]
16. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
17. Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):665-9. PubMed ID: 26809275
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium.
Stinson J; McCall C; Dobbs RW; Mistry N; Rosenberg A; Nettey OS; Sharma P; Dixon M; Sweis J; Macias V; Sharifi R; Kittles RA; Kajdacsy-Balla A; Murphy AB
Prostate; 2023 Mar; 83(4):352-363. PubMed ID: 36479698
[TBL] [Abstract][Full Text] [Related]
19. The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.
Atoum MF; AlKateeb D; AlHaj Mahmoud SA
Asian Pac J Cancer Prev; 2015; 16(6):2227-30. PubMed ID: 25824742
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
